NOV 14, 2019 12:00 PM PST

Panel Discussion: Emerging technologies in laboratory medicine, opportunities and challenges

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Corresponding member of IFCC C-MHBLM, North Sector POCT Medical Lead, Alberta Public Laboratories, Associate Clinical Professor of Laboratory Medicine, University of Alberta
    Biography
      Anna Füzéry obtained her PhD in biochemistry from the University of Wisconsin-Madison, and subsequently completed a 2-year postdoctoral training program in clinical chemistry at Johns Hopkins Medical Institutes in Baltimore, MD. She accepted a position as clinical chemist for Alberta Health Services in 2013, where she oversaw high volume general chemistry testing at 11 laboratories in Edmonton, Alberta. She became medical lead of point-of-care testing (POCT) for Edmonton in 2017, and for the northern half of the province of Alberta in 2019. Her current interest is in enabling high quality, clinically relevant POCT in mobile health environments.
    • Professor, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc
      Biography
        Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.

      Abstract

      Part 1: Sustainable health and laboratory medicine; Presented by Professor Damien Gruson

      Summary: Chronic diseases such as diabetes, cardiovascular diseases, renal failure orcancer are associated with high morbidity and mortality and contribute to a very important part of health expenditure. The prevalence of chronic diseases is increasing also because an aging population. The optimization of the diagnosis and monitoring of patients with chronic diseases is a major challenge in an era of healthcare workforces shortage and budget limitations.

      Emerging technologies are shifting the paradigm of the management of chronic diseases and of the interactions within the healthcare ecosystem. The testing loop process is also transforming with more capacity of remote monitoring. The evolutions of the pre-analytical phase consider now the citizen and patient literacy as well as their empowerment in disease prevention and monitoring. Measurements are shifting because of new generation of sensors and point of care systems.  The role of specialists in laboratory medicine now also includes the validation of these novel technologies, the education of the caregivers and the management of data as the volume of data generated is exponentially increasing. Emerging technologies represent also additional supports for integrated care pathways and multidisciplinary interactions.

      Part 2: Let’s talk about errors in point of care testing in mobile health environments; Presented by Dr. Anna Fuezery

      Summary: The presentation will first review our current understanding of errors in point of care testing (POCT), with a particular emphasis on mobile health environments. The presentation will then discuss general approaches to POCT error quantification, monitoring, and mitigation, as well as the relevance of such approaches to mobile health environments. 

       


      Show Resources
      You May Also Like
      JUN 09, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 09, 2020 10:00 AM PDT
      DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
      AUG 25, 2020 8:00 AM PDT
      C.E. CREDITS
      AUG 25, 2020 8:00 AM PDT
      DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
      OCT 08, 2020 7:00 AM PDT
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      JUN 23, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 23, 2020 10:00 AM PDT
      DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
      AUG 18, 2020 10:00 AM PDT
      C.E. CREDITS
      AUG 18, 2020 10:00 AM PDT
      DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      Loading Comments...
      Show Resources
      Attendees
      • See more